Antibodies against SUMO4 polypeptides
View Patent ↗Antibodies selectively directed against SUM04 polypeptides are provided. The antibodies are useful research tools and further in the diagnosis and treatment of Type 1 diabetes.
1. An isolated antibody that selectively binds to a polypeptide as defined in SEQ ID NO:2 over a polypeptide as defined in SEQ ID NO:4.
2. An isolated antibody that selectively binds to a SUMO4 polypeptide over other polypeptides, wherein the SUMO4 polypeptide is selected from the group consisting of:
a) a polypeptide comprising an amino acid sequence as defined in SEQ ID NO:2 or SEQ ID NO:4; and
b) a polypeptide comprising an amino acid sequence having at least 99% sequence identity with the SUMO4 polypeptide as defined in SEQ ID NO:2 or SEQ ID NO:4.
3. The antibody of claim 2 , wherein the SUMO4 polypeptide comprises an amino acid sequence as defined in SEQ ID NO:2 or SEQ ID NO:4.
4. The antibody of claim 2 , wherein the SUMO4 polypeptide comprises an amino acid sequence having at least 99% sequence identity with the polypeptide as defined in SEQ ID NO:2 or SEQ ID NO:4.
5. The antibody of claim 2 , wherein the SUMO4 polypeptide comprises an amino acid sequence as defined in SEQ ID NO:2.
6. The antibody of claim 2 , wherein the SUMO4 polypeptide comprises an amino acid sequence as defined in SEQ ID NO:4.